Smith & Nephew Buys Ceterix Orthopedics for up to $105M

Smith & Nephew, the global medical technology business, today announces that it has agreed to acquire Ceterix® Orthopaedics, Inc, the developer of the NovoStitch® Pro Meniscal Repair System. This unique device addresses complex meniscal tear patterns not adequately served by other repair systems. It is highly complementary to Smith & Nephew’s leading FAST-FIX◊ 360 Meniscal Repair System, which addresses vertical…

Read More

PeekMed Receives FDA 510(k) Clearance for Orthopedic Planning System

PeekMed® reached 510(k) clearance for its orthopedic planning system, from the U.S. Food and Drug Administration (FDA), after regulatory approval in the European Union, and successfully working with more than 1100 surgeons. Developing a product in the medical field is highly demanding when it comes to regulation.Only a few European companies achieve certification in the USA due to the detailed…

Read More

Nexxt Spine Receives 510(k) for Posterior Cervical Spine System

Nexxt Spine has received FDA 510(k) clearance and has commercially launched its Saxxony Posterior Cervical Thoracic System. The system is designed to stabilize cervical (C1 to C7) and thoracic (T1 to T3) spinal segments through posterior screw fixation. “The Saxxony System adds a robust posterior complement to our well received anterior cervical fixation offering as…

Read More

RTI Surgical to Acquire Paradigm Spine for $300M

RTI Surgical, Inc., a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million,…

Read More

Stryker to acquire K2M for $1.4B

Stryker said today it inked a definitive agreement to acquire K2M for approximately $1.4 billion. In the deal, Kalamazoo, Mich.-based Stryker said it will pay $27.50 per share for each outstanding share of K2M, for a total of approximately $1.4 billion. The purchase price represents a 27% premium over K2M’s average closing price during the 90 days of…

Read More

Wright Medical to Buy Orthopaedic Company Cartiva for $435M

Wright Medical Group announced it has entered into a definitive agreement to acquire Cartiva, Inc., a private orthopaedic medical device company focused on treatment of osteoarthritis of the great toe.  The transaction will add a differentiated PMA-approved technology for a high-volume foot and ankle procedure and further accelerates growth opportunities in Wright’s global Extremities business. Under…

Read More

FDA Warning Letter Issued to Zimmer Biomet’s Indiana Manufacturing Site

Zimmer Biomet received a warning letter from the FDA about quality violations found at a plant in Warsaw, Indiana. The agency had flagged the issues after a 2016 inspection of the site, but found in a re-inspection earlier this year that the company’s resolution was not up to par. The FDA inspected Zimmer Biomet’s North…

Read More

FDA Approval for Ceterix Orthopaedics New Suture Cartridge

Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an added feature to the NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears. The NovoStitch Pro system enables…

Read More

Siemens & Nuvasive Partner on Spinal Surgery Workflow Development

NuVasive said last week it had inked a strategic partnership deal with Siemens Healthineers looking to develop and advance technology designed for minimally invasive spinal surgery. Through the deal, dubbed the Spine Precision Partnership, the companies will look to jointly advance their proprietary technologies, looking to improve operating room workflow efficiency and the delivery of minimally disruptive spinal…

Read More

Magnetic Surgical Cement Pulls Chemotherapy Drugs across Blood-Brain Barrier into Spinal Tumors

Patients with spinal fractures caused by tumors or osteoporosis usually undergo a procedure called kyphoplasty, where the fracture is filled with surgical cement. While kyphoplasty can stabilize the bone, cancer patients are still often left with spinal column tumors that are very hard to reach with conventional chemotherapy, which has to cross the blood-brain barrier…

Read More